Market Share of Asia-Pacific Insulin Delivery Devices Industry
The market is consolidated, with few players holding a significant market share in the current year. However, the insulin syringe market is highly fragmented, and many market players are based locally. Companies to expand their market presence are investing in R&D and collaborating with other major players to develop innovative solutions. Abbott and Novo Nordisk partnered to provide an integrated digital solution to people with diabetes using insulin. The collaboration may enable insulin data to be shared between Novo Nordisk's connected insulin pens and digital health tools compatible with the FreeStyle Libre portfolio of products.
Asia-Pacific Insulin Delivery Devices Market Leaders
Novo Nordisk
Medtronic
Sanofi
Eli Lilly and Company
Ypsomed Holding
*Disclaimer: Major Players sorted in no particular order
